Your browser doesn't support javascript.
loading
Author Correction: Targeting the DYRK1A kinase prevents cancer progression and metastasis and promotes cancer cells response to G1/S targeting chemotherapy drugs.
Laham, Amina Jamal; El-Awady, Raafat; Saber-Ayad, Maha; Wang, Ni; Yan, Gang; Boudreault, Julien; Ali, Suhad; Lebrun, Jean-Jacques.
Afiliación
  • Laham AJ; Department of Medicine, Cancer Research Program, McGill University Health Center, Montreal, Quebec, H4A 3J1, Canada.
  • El-Awady R; College of Medicine, University of Sharjah, Sharjah, 27272, United Arab Emirates.
  • Saber-Ayad M; Research Institute for Medical and Health Sciences, University of Sharjah, Sharjah, 27272, United Arab Emirates.
  • Wang N; Research Institute for Medical and Health Sciences, University of Sharjah, Sharjah, 27272, United Arab Emirates. relawady@sharjah.ac.ae.
  • Yan G; College of Pharmacy, University of Sharjah, Sharjah, 27272, United Arab Emirates. relawady@sharjah.ac.ae.
  • Boudreault J; College of Medicine, University of Sharjah, Sharjah, 27272, United Arab Emirates.
  • Ali S; Research Institute for Medical and Health Sciences, University of Sharjah, Sharjah, 27272, United Arab Emirates.
  • Lebrun JJ; Department of Medicine, Cancer Research Program, McGill University Health Center, Montreal, Quebec, H4A 3J1, Canada.
NPJ Precis Oncol ; 8(1): 141, 2024 Jul 08.
Article en En | MEDLINE | ID: mdl-38977910

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: NPJ Precis Oncol Año: 2024 Tipo del documento: Article País de afiliación: Canadá

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: NPJ Precis Oncol Año: 2024 Tipo del documento: Article País de afiliación: Canadá